Cas:1185763-69-2 NVP-BVU972 manufacturer & supplier

Chemical Name:NVP-BVU972

CAS.NO:1185763-69-2

Synonyms:BVU972;cc-601;CS-0967;6-((6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl)methyl)quinoline;6-{[6-(1-Methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]methyl}quinoline;3qti;Quinoline, 6-[[6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]methyl]-;NVPBVU972;NVP-BVU972

Molecular Formula:C₂₀H₁₆N₆

Molecular Weight:340.381

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.4±0.1 g/cm3

Index of Refraction:1.745

PSA:60.90000

Exact Mass:340.143646

LogP:2.12

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like BVU972 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,NVP-BVU972 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,cc-601 Use and application,CS-0967 technical grade,usp/ep/jp grade.

Related News: “We were all surprised by the speed at which the oncology market grew in China,” Dunoyer said on the call. “Even if we don’t expect rare disease to grow at the same speed, it is likely that the speed at which the rare disease grows in China is going to be faster than other markets of the world.” Fmoc-Phe(3-Cl)-OH manufacturers Officials did, however, acknowledge that there’s growing evidence an extra jab may enhance the antibody response in immunocompromised people. Some small studies suggest up to 50% of people with no antibody response after the authorized regimen of two mRNA jabs developed a response after an additional dose, said CDC’s Sara Oliver, M.D. 1-bromohexadecan-2-one suppliers EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. pentanoic-5,5,5-d3 acid vendor & factory.